Deep Medicine Acquisition Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Humphrey Polanen

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	3.3yrs
CEO ownership	0.6%
Management average tenure	no data
Board average tenure	1.9yrs

Recent management updates

Recent updates

CEO

Humphrey Polanen (73 yo)

3.3yrs

Tenure

Mr. Humphrey P. Polanen, J.D. serves as Outside Independent Director of Techflow, Inc. since February 2017. He is an Advisor, Silicon Valley and Asia operations at Tensor Ventures. He serves as Advisor at...

Board Members

Name	Position	Tenure	Compensation	Ownership
Humphrey Polanen	CEO & Chairman of the Board	3.3yrs	no data	0.57% $ 209.7k
John Chiang	Independent Director	1.3yrs	no data	no data
Riley Russell	Director	no data	no data	no data
Ronald Razmi	Director	3.1yrs	no data	1.15% $ 419.5k
Tina Spires	Independent Director	2.6yrs	no data	no data
HongLiang Ren	Independent Director	2.8yrs	no data	no data
Wanlei Miao	Independent Director	2.6yrs	no data	no data
AJ Redmer	Director	no data	no data	no data
Christopher Jones	Director	no data	no data	no data
Shaun Limbers	Director	no data	no data	no data

1.9yrs

Average Tenure

48.5yo

Average Age

Experienced Board: DMAQ's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Deep Medicine Acquisition Management

Management criteria checks 0/4

Key information

Recent management updates

Deep Medicine Acquisition Corp. Approves the Election of Directors

Deep Medicine Acquisition Corp., Annual General Meeting, Dec 23, 2022

Deep Medicine Acquisition Corp. Appoints John Chiang as Member to its Board of Directors

Recent updates

Trugolf, Inc. completed the acquisition of Deep Medicine Acquisition Corp. (NasdaqCM:DMAQ) from a group of shareholders in a reverse merger transaction.